Lumen Bioscience Funding: $185M Raised, Series C (2025)
Lumen Bioscience is a Biotech company based in Seattle. It has raised $185M in total funding. Latest round: Series C.
Lumen Bioscience funding overview
Lumen Bioscience is a Biotech company based in Seattle. Lumen Bioscience has raised $185M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in January 2025. The round record for Lumen Bioscience runs through 2025; nothing later has been disclosed. Investors on record include WestRiver Group, Gates Foundation. 2 distinct backers are named across the disclosed rounds.
Lumen Bioscience at a glance
Total raised
$185M
Latest round
Series C
Latest round date
January 2025
Industry
Biotech
Headquarters
Seattle
Notable investors
WestRiver Group, Gates Foundation
Frequently asked about Lumen Bioscience funding
How much has Lumen Bioscience raised?
Lumen Bioscience has raised $185M in total disclosed funding across the rounds on record.
Who has invested in Lumen Bioscience?
WestRiver Group, Gates Foundation are named among the investors backing Lumen Bioscience.
What was the latest Lumen Bioscience funding round?
The most recent disclosed round is a Series C, announced in January 2025.
Where is Lumen Bioscience based?
Lumen Bioscience is based in Seattle.
What sector does Lumen Bioscience operate in?
Lumen Bioscience is tracked under Biotech from Seattle, with $185M in disclosed funding.
When did Lumen Bioscience last raise?
The last disclosed Lumen Bioscience round closed in January 2025 at Series C.
Round data for Lumen Bioscience is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Biotech companies in Seattle and backer lists below.
